Login to Your Account

Another Day and Another Biotech IPO: Ophthotech Files

By Marie Powers
Staff Writer

Monday, August 19, 2013

Eye disease specialist Ophthotech Corp. became the 30th biotech this year to pursue an initial public offering (IPO), seeking to raise $85 million, according to its Form S-1 filed with the SEC Friday. The company did not disclose the number of shares or price range in the offering.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription